I

Intend Research | Norman, OK

Research site
(Unclaimed)
Location
1010 24th Avenue NW, Suite 110, Norman, Oklahoma, United States of America
Site insights

Top conditions

Diabetes Mellitus (23 trials)

Type 2 Diabetes Mellitus (20 trials)

Obesity (8 trials)

Overweight (8 trials)

Type 1 Diabetes Mellitus (3 trials)

Top treatments

Tirzepatide
LY3298176
Metformin
LY3502970
LY3209590
Orforglipron
LY3437943
JNJ-42847922
Glimepiride
Pemafibrate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

12 of 38
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-2)

The purpose of this study is to determine the effect and safety of insulin efsitora alfa (LY3209590) compared to degludec in adult participants with...

Active, not recruiting
Diabetes
Type 2 Diabetes
Drug: Insulin Degludec
Drug: Insulin Efsitora Alfa
Locations recently updated

The main purpose of this study is to determine the efficacy and safety of insulin efsitora alfa (LY3209590) administered weekly using a fixed dose es...

Active, not recruiting
Type 2 Diabetes
T2D
Drug: Insulin Glargine
Drug: Insulin Efsitora Alfa
Locations recently updated

The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes th...

Active, not recruiting
Type 2 Diabetes
Drug: Insulin Efsitora Alfa
Drug: Insulin Degludec
Locations recently updated

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes a...

Enrolling
Type 2 Diabetes
Drug: Orforglipron
Drug: Semaglutide
Locations recently updated

This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-rela...

Active, not recruiting
Overweight or Obesity
Overweight
Drug: Placebo
Drug: Orforglipron
Locations recently updated

The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes a...

Enrolling
Type 2 Diabetes
Drug: Orforglipron
Drug: Placebo

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide
Locations recently updated

The main purpose of this study is to investigate the efficacy and safety of switching from weekly dulaglutide to weekly tirzepatide compared to incre...

Active, not recruiting
Type 2 Diabetes
Drug: Tirzepatide
Drug: Dulaglutide
Locations recently updated

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weig...

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Placebo

The main purpose of this phase 3b study is to evaluate the efficacy and safety of tirzepatide compared with semaglutide in adult participants who hav...

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Semaglutide

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo
Locations recently updated

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes and...

Enrolling
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Retatrutide

Trial sponsors

Lilly logo

Lilly (26 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems